Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05671406 · ClinicalTrials.gov registry record · NA

RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community

A NA study of Hypertension, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT05671406: Recruiting NA study of Hypertension, sponsored by University of Texas at Austin.

NCT05671406 is a NA study of Hypertension that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 220 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05671406, a NA study of Hypertension, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of physical activity in Native American adults with hypertension (HTN). Half of the participants will receive the SCDG app and physical activity sensors and the other half will receive only the physical activity sensors. Native American participants with hypertension (HTN) in the sensor controlled digital game intervention group will show increased PA behaviors; improved HTN knowledge, self-care behaviors, self-efficacy, motivation, and quality of life (QoL); and larger reduction in systolic and diastolic blood pressure and cardiac hospitalizations at baseline,3 months, and 6 months as compared to participants in the sensor-only control group.

Primary Outcome

This outcome measure will be measured by calculating the average daily steps at end of 3 months. These measures will be collected from sensor logs within the apps for both IG and CG.

Conditions Studied

Interventions

  • BEHAVIORAL Sensor-controlled digital game
  • BEHAVIORAL Sensor only

Study Locations (1)

North Carolina

  • University of North Carolina Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2024-06-27
Est. Completion 2027-03-31
Phase NA
University of Texas at Austin

257 total trials

What NCT05671406 shows while recruiting

NCT05671406 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Sensor-controlled digital game is the first listed.

NCT05671406 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05671406 about?

NCT05671406 is a clinical study titled "RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community". This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of physical activity in Native American adults with hypertension (HTN). Half of the participants will receive the SCDG app and physical activity sensors and the other half will receive only the physica...

What is the current status of trial NCT05671406?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2024-06-27. Estimated completion is 2027-03-31.

What conditions does trial NCT05671406 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT05671406?

The interventions under investigation include: Sensor-controlled digital game (BEHAVIORAL), Sensor only (BEHAVIORAL).

Who is sponsoring clinical trial NCT05671406?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05671406 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05671406's enrollment target sits among peer trials

220 206th of 470 higher than 262 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05671406, the US trial registry maintained by the National Library of Medicine. NCT05671406 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.